PubMed

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes.

Mittendorf EA, Wu Y, Scaltriti M, Meric-Bernstam F, Hunt KK, Dawood S, Esteva FJ, Buzdar AU, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AM.

Clin Cancer Res. 2009 Nov 17. [Epub ahead of print]PMID: 19920100 [PubMed - as supplied by publisher]Related articles

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or Smaller.

Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN.

J Clin Oncol. 2009 Nov 2. [Epub ahead of print]PMID: 19884543 [PubMed - as supplied by publisher]Related articles

Effects of chronic hepatitis C infection on the treatment of breast cancer patients.

Morrow PK, Tarrand JJ, Taylor SH, Kau SW, Theriault RL, Hortobagyi GN, Broglio KR, Hahn KM.

Ann Oncol. 2009 Oct 29. [Epub ahead of print]PMID: 19875760 [PubMed - as supplied by publisher]Related articles

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).

Slovak ML, Bedell V, Lew D, Albain KS, Ellis GK, Livingston RB, Martino S, Perez EA, Hortobagyi GN, Sher D, Stock W.

Breast Cancer Res Treat. 2009 Oct 23. [Epub ahead of print]PMID: 19851858 [PubMed - as supplied by publisher]Related articles

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer.

Zhang D, LaFortune TA, Krishnamurthy S, Esteva FJ, Cristofanilli M, Liu P, Lucci A, Singh B, Hung MC, Hortobagyi GN, Ueno NT.

Clin Cancer Res. 2009 Nov 1;15(21):6639-48. Epub 2009 Oct 13.PMID: 19825949 [PubMed - in process]Related articles

Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.

Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA.

J Am Coll Surg. 2009 Oct;209(4):425-433.e2. Epub 2009 Aug 20.PMID: 19801315 [PubMed - indexed for MEDLINE]Related articles

Neoadjuvant Chemotherapy.

Green MC, Esteva FJ, Hortobagyi GN.

Breast Dis. 2009 Sep 3;21:23-31. [Epub ahead of print] No abstract available. PMID: 19729775 [PubMed - as supplied by publisher]Related articles

Role of anthracyclines in the treatment of early breast cancer.

Gianni L, Norton L, Wolmark N, Suter TM, Bonadonna G, Hortobagyi GN.

J Clin Oncol. 2009 Oct 1;27(28):4798-808. Epub 2009 Aug 17. Review.PMID: 19687331 [PubMed - indexed for MEDLINE]Related articles

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.

Pusztai L, Jeong JH, Gong Y, Ross JS, Kim C, Paik S, Rouzier R, Andre F, Hortobagyi GN, Wolmark N, Symmans WF.

J Clin Oncol. 2009 Sep 10;27(26):4287-92. Epub 2009 Aug 10.PMID: 19667268 [PubMed - indexed for MEDLINE]Related articles

Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer.

Ueno NT, de Souza JA, Booser D, Nakayama K, Madewell J, Wendt RE 3rd, Hortobagyi GN, Podoloff D, Champlin RE.

Clin Breast Cancer. 2009 Aug;9(3):173-7.PMID: 19661041 [PubMed - indexed for MEDLINE]Related articles

Management of breast cancer in the genome era.

Morrow PK, Hortobagyi GN.

Annu Rev Med. 2009;60:153-65. Review.PMID: 19630569 [PubMed - indexed for MEDLINE]Related articles

Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.

Liedtke C, Wang J, Tordai A, Symmans WF, Hortobagyi GN, Kiesel L, Hess K, Baggerly KA, Coombes KR, Pusztai L.

Breast Cancer Res Treat. 2009 Jul 15. [Epub ahead of print]PMID: 19603265 [PubMed - as supplied by publisher]Related articles

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Mego M, Doyle GV, Miller MC, Ueno NT, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

Ann Oncol. 2009 Jul 14. [Epub ahead of print]PMID: 19602564 [PubMed - as supplied by publisher]Related articles

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.

Liedtke C, Broglio K, Moulder S, Hsu L, Kau SW, Symmans WF, Albarracin C, Meric-Bernstam F, Woodward W, Theriault RL, Kiesel L, Hortobagyi GN, Pusztai L, Gonzalez-Angulo AM.

Ann Oncol. 2009 Jul 12. [Epub ahead of print]PMID: 19596702 [PubMed - as supplied by publisher]Related articles

Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization.

Sparano JA, Hortobagyi GN, Gralow JR, Perez EA, Comis RL.

Breast Cancer Res Treat. 2009 Jun 14. [Epub ahead of print]PMID: 19526354 [PubMed - as supplied by publisher]Related articles

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM.

J Clin Oncol. 2009 Jul 10;27(20):3297-302. Epub 2009 Jun 1.PMID: 19487376 [PubMed - indexed for MEDLINE]Related articles

Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.

Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, Lewis VO, Ma J, Stafford RJ, Tari AM, Hortobagyi GN, Ueno NT.

Lancet Oncol. 2009 Jun;10(6):606-14. Review.PMID: 19482249 [PubMed - indexed for MEDLINE]Related articles

Topoisomerase II{alpha} amplification and anthracycline-based chemotherapy: the jury is still out.

Esteva FJ, Hortobagyi GN.

J Clin Oncol. 2009 Jul 20;27(21):3416-7. Epub 2009 May 26. No abstract available. PMID: 19470912 [PubMed - indexed for MEDLINE]Related articles

Breast cancer metastasis: challenges and opportunities.

Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, Cristofanilli M, Dontu G, Bidaut L, Valero V, Hortobagyi GN, Yu D.

Cancer Res. 2009 Jun 15;69(12):4951-3. Epub 2009 May 26. No abstract available. PMID: 19470768 [PubMed - indexed for MEDLINE]Related articles

Molecular targets for treatment of inflammatory breast cancer.

Yamauchi H, Cristofanilli M, Nakamura S, Hortobagyi GN, Ueno NT.

Nat Rev Clin Oncol. 2009 Jul;6(7):387-94. Epub 2009 May 26. Review.PMID: 19468291 [PubMed - indexed for MEDLINE]Related articles

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

J Clin Oncol. 2009 Jul 10;27(20):3303-11. Epub 2009 May 18.PMID: 19451443 [PubMed - indexed for MEDLINE]Related articles

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB.

Cancer Res. 2009 May 15;69(10):4116-24. Epub 2009 May 12.PMID: 19435916 [PubMed - indexed for MEDLINE]Related articles

Future of cancer incidence in the United States: burdens upon an aging, changing nation.

Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA.

J Clin Oncol. 2009 Jun 10;27(17):2758-65. Epub 2009 Apr 29.PMID: 19403886 [PubMed - indexed for MEDLINE]Related articles

Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases.

Ma J, Costelloe CM, Madewell JE, Hortobagyi GN, Green MC, Cao G, Sun F, Kundra V.

J Magn Reson Imaging. 2009 May;29(5):1154-62.PMID: 19388121 [PubMed - indexed for MEDLINE]Related articles

Genomic grade index is associated with response to chemotherapy in patients with breast cancer.

Liedtke C, Hatzis C, Symmans WF, Desmedt C, Haibe-Kains B, Valero V, Kuerer H, Hortobagyi GN, Piccart-Gebhart M, Sotiriou C, Pusztai L.

J Clin Oncol. 2009 Jul 1;27(19):3185-91. Epub 2009 Apr 13.PMID: 19364972 [PubMed - indexed for MEDLINE]Related articles

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.

Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN.

Oncologist. 2009 Apr;14(4):320-68. Epub 2009 Apr 3. Review.PMID: 19346299 [PubMed - indexed for MEDLINE]Related articles

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.

Srokowski TP, Fang S, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2009 May 1;27(13):2170-6. Epub 2009 Mar 23.PMID: 19307509 [PubMed - indexed for MEDLINE]Related articles

Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.

Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK.

Cancer. 2009 Apr 15;115(8):1598-604.PMID: 19280625 [PubMed - indexed for MEDLINE]Related articles

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

Gonzalez-Angulo AM, Stemke-Hale K, Palla SL, Carey M, Agarwal R, Meric-Berstam F, Traina TA, Hudis C, Hortobagyi GN, Gerald WL, Mills GB, Hennessy BT.

Clin Cancer Res. 2009 Apr 1;15(7):2472-8. Epub 2009 Mar 10.PMID: 19276248 [PubMed - indexed for MEDLINE]Related articles

Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.

Yang WT, Lewis MT, Hess K, Wong H, Tsimelzon A, Karadag N, Cairo M, Wei C, Meric-Bernstam F, Brown P, Arun B, Hortobagyi GN, Sahin A, Chang JC.

Breast Cancer Res Treat. 2009 Feb 25. [Epub ahead of print]PMID: 19241157 [PubMed - as supplied by publisher]Related articles

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells.

Nakayama S, Torikoshi Y, Takahashi T, Yoshida T, Sudo T, Matsushima T, Kawasaki Y, Katayama A, Gohda K, Hortobagyi GN, Noguchi S, Sakai T, Ishihara H, Ueno NT.

Breast Cancer Res. 2009;11(1):R12. Epub 2009 Feb 24.PMID: 19239702 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.

Cabioglu N, Sahin AA, Morandi P, Meric-Bernstam F, Islam R, Lin HY, Bucana CD, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M.

Ann Oncol. 2009 Jun;20(6):1013-9. Epub 2009 Feb 23.PMID: 19237480 [PubMed - indexed for MEDLINE]Related articles

High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.

Arun B, Vogel KJ, Lopez A, Hernandez M, Atchley D, Broglio KR, Amos CI, Meric-Bernstam F, Kuerer H, Hortobagyi GN, Albarracin CT.

Cancer Prev Res (Phila Pa). 2009 Feb;2(2):122-7. Epub 2009 Jan 27.PMID: 19174581 [PubMed - indexed for MEDLINE]Related articles

Survival among women with triple receptor-negative breast cancer and brain metastases.

Dawood S, Broglio K, Esteva FJ, Yang W, Kau SW, Islam R, Albarracin C, Yu TK, Green M, Hortobagyi GN, Gonzalez-Angulo AM.

Ann Oncol. 2009 Apr;20(4):621-7. Epub 2009 Jan 15.PMID: 19150943 [PubMed - indexed for MEDLINE]Related articles

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, Delaloge S, Hortobagyi GN, Symmans WF, Lazar V, Pusztai L.

Clin Cancer Res. 2009 Jan 15;15(2):441-51.PMID: 19147748 [PubMed - indexed for MEDLINE]Related articles

Accuracy of the BRCAPRO model among women with bilateral breast cancer.

Ready KJ, Vogel KJ, Atchley DP, Broglio KR, Solomon KK, Amos C, Lu KH, Hortobagyi GN, Arun B.

Cancer. 2009 Feb 15;115(4):725-30.PMID: 19127556 [PubMed - indexed for MEDLINE]Related articles

Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer.

Gonzalez-Angulo AM, Walters R, Broglio K, Frye DK, Strom EA, Theriault RL, Booser DJ, Valero V, Buzdar AU, Hortobagyi GN.

Clin Breast Cancer. 2008 Dec;8(6):516-21.PMID: 19073507 [PubMed - indexed for MEDLINE]Related articles

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.

Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R.

Clin Breast Cancer. 2008 Dec;8(6):511-5.PMID: 19073506 [PubMed - indexed for MEDLINE]Related articles

Ductal carcinoma in situ: state of the science and roadmap to advance the field.

Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN.

J Clin Oncol. 2009 Jan 10;27(2):279-88. Epub 2008 Dec 8. Review.PMID: 19064970 [PubMed - indexed for MEDLINE]Related articles

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.

Dawood S, Broglio K, Kau SW, Green MC, Giordano SH, Meric-Bernstam F, Buchholz TA, Albarracin C, Yang WT, Hennessy BT, Hortobagyi GN, Gonzalez-Angulo AM.

J Clin Oncol. 2009 Jan 10;27(2):220-6. Epub 2008 Dec 1.PMID: 19047281 [PubMed - indexed for MEDLINE]Related articles

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.

Moulder SL, Symmans WF, Booser DJ, Madden TL, Lipsanen C, Yuan L, Brewster AM, Cristofanilli M, Hunt KK, Buchholz TA, Zwiebel J, Valero V, Hortobagyi GN, Esteva FJ.

Clin Cancer Res. 2008 Dec 1;14(23):7909-16.PMID: 19047121 [PubMed - indexed for MEDLINE]Related articles

A time for creative collaboration.

Hortobágyi GN.

Cancer. 2008 Oct 15;113(8 Suppl):2217-20. No abstract available. PMID: 18837030 [PubMed - indexed for MEDLINE]Related articlesFree article

Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries.

El Saghir NS, Eniu A, Carlson RW, Aziz Z, Vorobiof D, Hortobagyi GN; Breast Health Global Initiative Systemic Therapy Focus Group.

Cancer. 2008 Oct 15;113(8 Suppl):2315-24.PMID: 18837023 [PubMed - indexed for MEDLINE]Related articlesFree article

Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation.

Shyyan R, Sener SF, Anderson BO, Garrote LM, Hortobágyi GN, Ibarra JA Jr, Ljung BM, Sancho-Garnier H, Stalsberg H; Breast Health Global Initiative Diagnosis Panel.

Cancer. 2008 Oct 15;113(8 Suppl):2257-68.PMID: 18837018 [PubMed - indexed for MEDLINE]Related articlesFree article

Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?

Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M.

Cancer. 2008 Nov 1;113(9):2422-30.PMID: 18785255 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK.

J Clin Oncol. 2008 Sep 10;26(26):4282-8.PMID: 18779615 [PubMed - indexed for MEDLINE]Related articles

Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.

Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM.

J Clin Oncol. 2008 Sep 1;26(25):4072-7.PMID: 18757321 [PubMed - indexed for MEDLINE]Related articles

Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer.

Dawood S, Broglio K, Gonzalez-Angulo AM, Buzdar AU, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2008 Oct 20;26(30):4891-8. Epub 2008 Aug 25.PMID: 18725649 [PubMed - indexed for MEDLINE]Related articlesFree article

Staging of breast cancer in the neoadjuvant setting.

Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK.

Cancer Res. 2008 Aug 15;68(16):6477-81. Review.PMID: 18701468 [PubMed - indexed for MEDLINE]Related articlesFree article

Residual risk of breast cancer recurrence 5 years after adjuvant therapy.

Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ.

J Natl Cancer Inst. 2008 Aug 20;100(16):1179-83. Epub 2008 Aug 11.PMID: 18695137 [PubMed - indexed for MEDLINE]Related articlesFree article